BACKGROUND: European cooperation on HTA has been in place for several years, including the EUnetHTA project and three Joint Actions (JAs), EUnetHTA JA 1-3. The aim of the joint work is to support evidence-based, sustainable and equitable choices in healthcare and health technologies and thus to support public health across Member states (MS).*** DESCRIPTION OF THE PROBLEM:
As EUnetHTA JA 3 ends in 2020, the European Commission (EC) started an impact assessment process in 2016 to identify a sustainable mechanism for further cooperation after 2020. In the context of this initiative, potential policy options were published by the EC and several supporting studies were conducted. Our study aimed to answer the following key questions: How do the current systems of HTA in Europe affect the key stakeholders (HTA bodies, industry etc)? How would the proposed policy options affect the key stakeholders?